Amicus Therapeutics (FOLD) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $2.93.
- Amicus Therapeutics' Times Interest Earned rose 7147.43% to $2.93 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.7, marking a year-over-year increase of 58040.01%. This contributed to the annual value of $0.5 for FY2024, which is 13257.61% up from last year.
- According to the latest figures from Q3 2025, Amicus Therapeutics' Times Interest Earned is $2.93, which was up 7147.43% from -$0.82 recorded in Q2 2025.
- Over the past 5 years, Amicus Therapeutics' Times Interest Earned peaked at $2.93 during Q3 2025, and registered a low of -$9.25 during Q1 2022.
- Over the past 5 years, Amicus Therapeutics' median Times Interest Earned value was -$2.23 (recorded in 2024), while the average stood at -$2.75.
- In the last 5 years, Amicus Therapeutics' Times Interest Earned soared by 56402.03% in 2024 and then crashed by 16848.25% in 2025.
- Amicus Therapeutics' Times Interest Earned (Quarter) stood at -$8.84 in 2021, then surged by 56.83% to -$3.82 in 2022, then soared by 92.46% to -$0.29 in 2023, then surged by 564.02% to $1.34 in 2024, then skyrocketed by 119.1% to $2.93 in 2025.
- Its Times Interest Earned was $2.93 in Q3 2025, compared to -$0.82 in Q2 2025 and -$0.69 in Q1 2025.